CVS MinuteClinic’s new $49 virtual GLP-1 program matches Walgreens on price, but differentiation will still be difficult in a crowded telehealth weight loss market.
Doctors remain in charge of steering condition and treatment decisions, but have the added responsibility of interpreting chatbot guidance.
AbbVie’s $10.9 billion immunology bet highlights how acquisitions are increasingly used to fill pipeline gaps, while underscoring the pressure on buyers to convert promising assets into approved drugs and commercial success.
Americans are spending more on health and wellness, and the reasons have less to do with income than with institutional skepticism. That dynamic is creating a significant retail opportunity, one that major retailers are already moving to capture. "[Wellness] has evolved into a much broader concept that combines physical health and mental health and emotional balance and lifestyle habits and longevity," said EMARKETER analyst Rajiv Leventhal in a recent episode of "Behind the Numbers."
OpenLoop has a new offering to stand up telehealth brands in just one day, but speed will test patient trust, care quality, and oversight.
Morning Consult found the brand’s trust scores held up despite a wave of negative political and media attention.
General LLMs outperform clinical AI on medical tests, but physicians will still favor specialized tools for high-stakes care.
They must clearly distinguish their products from gray-market manufacturers caught in the FDA’s crosshairs.
AI Overviews answer many health questions directly, forcing online health brands to offer expertise and utility that users can’t skip.
As another state gains permission to import drugs from Canada, it strengthens the case for narrowing the gap between US and foreign drug prices.
Nutrition information is earning more attention at the shelf, making front-of-pack labels a stronger influence on purchases.
Some patients forgo care after AI advice, creating health risks and urgency for provider-backed tools.
New deals with Nvidia and Lilly give Abridge validation from industry giants as it courts healthcare AI buyers.
While consumers trust doctors, they increasingly rely on AI and influencers for wellness advice, making misinformation more accessible and elevating the value of physician-backed brand content.
Pediatricians are vaccine makers' most effective channel to address rising parental concerns and counteract falling support for routine childhood immunization schedules.
Novo Nordisk’s oral obesity treatment is set for a private-pay debut in the UK as drugmakers look to broaden GLP-1 adoption beyond injections.
Nearly four in 10 say AI helped spot multiple potential mistakes over three months, pointing to the possibility of measurable patient-safety gains.
Hospitals have been warned over weak compliance with price transparency rules, but even full compliance would do little to help patients because insurer-provided out-of-pocket cost estimates are often more useful than raw service pricing data.
Unlike broad LLMs, Talkspace's AI companion tool adds therapist intervention when its AI detects a crisis, making safety its potential edge.
It’s approved for broader UV protection, which may spur uptake and challenge the high-SPF playbook lauded by popular skincare brands.